Internal Medicine, Gastroenterology · Atlanta, GA
NPI
1407850076
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
95 Collier Rd NW, Ste 4055
Atlanta, GA, 30309
Phone (404) 355-3200
Groups this clinician bills Medicare through
Medicare paid, 2024
$598K
19,733 services
Medicare patients, 2024
1,356
Average age 75
Drug cost, 2024
$2.2M
2,789 prescriptions
Company payments, 2025
$614
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randy J Yanda was code 88305 (surgical pathology examination), 836 times for 474 patients. In total Randy J Yanda billed 19,733 services in 46 codes, and Medicare paid $598K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 836 | 474 | $26.04 | $22K |
| 99214 Office E&M - Established | Office | 732 | 517 | $92.15 | $67K |
| 45385 Colonoscopy - Lesion Removal | Facility | 356 | 354 | $209.12 | $74K |
| 99213 Office E&M - Established | Office | 210 | 196 | $61.99 | $13K |
| 43239 Upper GI Endoscopy | Facility | 202 | 199 | $68.69 | $14K |
| 99204 Office E&M - New | Office | 137 | 137 | $116.27 | $16K |
| 45380 Lower GI Endoscopy - Other | Facility | 124 | 124 | $99.07 | $12K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 109 | 109 | $182.94 | $20K |
| 88313 Surgical Pathology Examination | Office | 109 | 99 | $56.87 | $6,199 |
| 99203 Office E&M - New | Office | 105 | 105 | $73.06 | $7,671 |
| 99232 Hospital E&M - Subsequent | Facility | 85 | 50 | $62.63 | $5,324 |
| 88312 Surgical Pathology Examination | Office | 76 | 67 | $69.35 | $5,271 |
| 43248 Upper GI Endoscopy | Facility | 64 | 60 | $112.55 | $7,203 |
| 99222 Hospital E&M - Initial | Facility | 46 | 45 | $103.87 | $4,778 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 39 | 39 | $183.31 | $7,149 |
By year: 2022 $461K for 14,911 services; 2023 $630K for 22,038 services; 2024 $598K for 19,733 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 836 | 474 | $26.04 | $22K |
| 88313 Surgical Pathology Examination | 109 | 99 | $56.87 | $6,199 |
| 88312 Surgical Pathology Examination | 76 | 67 | $69.35 | $5,271 |
Medicare prescription drug claims, 2024
In 2024, the drug Randy J Yanda prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 611 prescriptions and refills. In total Randy J Yanda wrote 2,789 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 611 | 635 | 595 | $40K |
| Pantoprazole Sodium Generic | 508 | 1,421 | 198 | $8,186 |
| Famotidine Generic | 287 | 739 | 110 | $3,343 |
| Omeprazole Generic | 214 | 559 | 95 | $2,611 |
| Dicyclomine Hcl Generic | 137 | 208 | 49 | $2,163 |
| Creon Lipase/Protease/Amylase | 85 | 116 | 19 | $241K |
| Mesalamine Generic | 67 | 113 | 15 | $23K |
| Lansoprazole Generic | 63 | 171 | 28 | $2,011 |
| Cholestyramine Cholestyramine (With Sugar) | 51 | 75 | 15 | $4,002 |
| Linzess Linaclotide | 49 | 101 | 16 | $53K |
| Esomeprazole Magnesium Generic | 45 | 117 | 16 | $1,674 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 41 | 44 | 13 | $809 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 38 | 38 | 38 | $623 |
| Lubiprostone Generic | 36 | 84 | 14 | $5,816 |
| Mesalamine Er Mesalamine | 36 | 100 | Under 11 | $16K |
Brand drugs: 459 claims; generic drugs: 2,330 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randy J Yanda $614 ($614 in general payments such as food, travel and fees) from 12 companies. The largest payer was Madrigal Pharmaceuticals with $142.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 7 | $142 |
| Boston Scientific Corporation BSX | 5 | $88.06 |
| Janssen Biotech, Inc. JNJ | 5 | $87.97 |
| Abbvie Inc. ABBV | 3 | $74.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $59.06 |
| Genzyme Corporation SNY | 2 | $51.7 |
| QOL Medical, LLC | 1 | $26.13 |
| Biocon Biologics Inc | 1 | $21.57 |
| Ardelyx, Inc. ARDX | 1 | $19.72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $15.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.